IRIS-AI
This innovation raises the bar in the field of eye care. In 2021, IRIS teamed up with Diagnos to offer its patients enhanced screening using a retinal camera assisted by artificial intelligence, maintaining its position as the industry leader in Canada.
artificial intelligence for the detection of eye diseases
Always on the lookout and at the forefront of new technologies, IRIS partnered with diagnos in June 2021. This collaboration allows IRIS patients to be screened by a retinal camera assisted by Artificial Intelligence during their visit with their optometrist. The use of Artificial Intelligence raises the standards for quality of care.
artificial intelligence for the detection of eye diseases
IRIS pioneer for the use of AI in optometry
The Artificial Intelligence on Retinal Imaging project is a first in our industry. IRIS has implemented, through its network, Artificial Intelligence for optometric practice. This technology combines the strength of its databases of fundus images with advanced diagnostic technology to provide a new tool for IRIS optometrists and a new service to patients.
who is Diagnos?
Founded in 1998, Diagnos is a Canadian company specializing in data mining, and A.I. Diagnos started conducting health research activities in 2005. Their first vision screening solution was launched in 2009 when it received Health Canada certification for medical devices.
data collection through CARA
Diagnos' analysis platform is called CARA for Computer Assisted Retina Analysis. CARA's image enhancement algorithms provide sharper, more precise, more analyzable retinal images. CARA is approved for commercialization by the following regulatory agencies: Health Canada, FDA (United States), C.E. (Europe), COFEPRIS (Mexico), and Saudi FDA (Saudi Arabia).
IRIS pioneer for the use of AI in optometry
A.I. in optometry makes it easier and faster to detect eye diseases during eye examinations. This system analyzes retinal images and provides optometrists with additional data to facilitate diagnosis. With this technology, it is possible to detect certain diseases that significantly impact eye health. Fundus imaging can detect conditions such as:
- Diabetic retinopathy
- Hypertensive retinopathy
- Macular degeneration
- Glaucoma
In addition to detecting these conditions, retinal camera screening assisted by artificial Intelligence helps determine the stage and rate of progression.
the results are in!
After testing this AI technology in 10 IRIS stores since 2021, IRIS has analyzed fundus photos for this project and has seen the benefits of offering this service to patients.
IRIS puts technology to work for optometrists
Annual eye health screening with artificial Intelligence can help detect diseases many years before the first symptoms appear. With Diagnos, IRIS enhances the quality of care and the patient experience once again!
